Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California
| Credit Types: | CME |
| Credit Amount: | 0.25 Credits |
| Release Date: | 2011-Dec-21 |
| Expiration Date: | 2012-Dec-20 |
| Estimated Time for Completion: | 15 minutes |
| Registration Required: | No |
| Cost: | Free |
In this activity, an expert in cosmetic dermatology addresses 3 key questions regarding the long-term effects of injectable dermal fillers and neurotoxins, optimal use of dermal fillers and neurotoxins, and emerging injectable products.
Upon completion of this activity, participants should be better able to:
This activity has been designed to meet the educational needs of cosmetic dermatologists and other healthcare professionals involved in the care of patients undergoing cosmetic dermatologic procedures.
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: December 21, 2011 - December 20, 2012
Time to Complete: 15 minutes
In accordance with ACCME requirements, the University of New Mexico Health Sciences Center, School of Medicine, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by UNM CME and conflicts of interest were resolved prior to the activity.
Rebecca Fitzgerald, MD
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, California
Rebecca Fitzgerald, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for sanofi-aventis U.S.
Grant/Research Support from Obagi Medical Products, Inc.
Speakers Bureau participant with Allergan, Inc.; Medicis Pharmaceutical Corporation; Merz Pharmaceuticals, LLC; and sanofi-aventis U.S.
Advisory Board for Obagi Medical Products, Inc. and sanofi-aventis U.S.
Phillip Strange, MD
Assistant Professor
Department of Dermatology
University of New Mexico Health Sciences Center, School of Medicine
Albuquerque, New Mexico
Phillip Strange, MD, currently has no financial interests/relationships or affiliations in relation to this activity.
Annette Wiggins
Answers in CME, Inc.
Annette Wiggins currently has no financial interests/relationships or affiliations in relation to this activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Health Sciences Center, School of Medicine and Answers in CME. The University of New Mexico Health Sciences Center, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of New Mexico Health Sciences Center, School of Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of New Mexico Health Sciences Center, School of Medicine and Answers in CME.
This activity is supported by an educational grant from 
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
To correct aging, which of the following areas of the face are best treated with dermal fillers and neurotoxins?
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.